Effect of sodium–glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: a systematic review and meta-analysis-论文-万方医学网

首页> > Effect of sodium–glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: a systematic review and meta-analysis

Effect of sodium–glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: a systematic review and meta-analysis

导出原文传递

翻译打印收藏纠错

第一作者： Mehmet,Kanbay

作者： Mehmet,Kanbay ^[1] ; Laura,Tapoi ^[2] ; Carina,Ureche ^[3] ; Cem,Tanriover ^[4] ; Enes,Cevik ^[5] ; Atalay,Demiray ^[6] ; Baris,Afsar ; David Z. I.,Cherney ; Adrian,Covic

作者单位： Division of Nephrology, Department of Medicine,Suleyman Demirel University School of Medicine ^[1] Division of Nephrology, Department of Medicine,Toronto General Hospital, University of Toronto ^[2] Cardiovascular Diseases Institute,“Gr. T. Popa” University of Medicine and Pharmacy ^[3] Department of Nephrology,“Grigore T. Popa” University of Medicine ^[4] Department of Medicine,Koc University School of Medicine ^[5] Division of Nephrology, Department of Medicine,Koc University School of Medicine ^[6]

关键词 SGLT2 inhibitors Anemia Diabetes mellitus Dapagliflozin Canagliflozin Empagliflozin Ipragliflozin

发布时间 2022-04-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Effect of sodium–glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: a systematic review and meta-analysis

相似文献

同项目论文

相关期刊

检索历史 清除

Effect of sodium–glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: a systematic review and meta-analysis

相似文献

同项目论文

相关期刊

检索历史清除